StockData
Palisade Bio, Inc. logo

Palisade Bio, Inc. (PALI) stock

PALINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$1.01−0.02 (-1.94%)

Close on Nov 17, 2026Market cap $176.01MP/E –Yield –

Palisade Bio total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Palisade Bio's total debt was $87.00K at Dec 31, 2021. For fiscal 2021 it was $87.00K, down 92.4% from the year before. The highest annual figure on record is $8.79M in fiscal 2014.

Annual total debt

PeriodPeriod endValueChange
FY2021Dec 31, 2021$87.00K-92.4%
FY2020Dec 31, 2020$1.14M-69.2%
FY2016Dec 31, 2016$3.71M-53.3%
FY2015Dec 31, 2015$7.93M-9.8%
FY2014Dec 31, 2014$8.79M+14.1%
FY2013Dec 31, 2013$7.70M–
FY2012Dec 31, 2012$0–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2021Dec 31, 2021$87.00K-96.6%
Q3 FY2021Sep 30, 2021$568.00K-84.7%
Q2 FY2021Jun 30, 2021$1.14M-76.4%
Q4 FY2020Dec 31, 2020$1.14M–
Q1 FY2017Mar 31, 2017$2.53M–
Q4 FY2016Dec 31, 2016$3.71M–
Q3 FY2016Sep 30, 2016$4.83M–

More Palisade Bio figures

See a number that looks wrong?